John L Rubinstein Selected Research

John L Rubinstein Research Topics

7	Infections 11/2023 - 01/2010
7	Neoplasms (Cancer) 05/2023 - 06/2014
2	Tuberculosis (Tuberculoses) 01/2021 - 01/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2019 - 10/2018
1	Arthrogryposis renal dysfunction cholestasis syndrome 01/2023
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2023
1	Malaria 11/2022
1	Osteoporosis 01/2022
1	Parasitic Diseases (Parasitic Disease) 01/2022
1	Leukemia 01/2022
1	Tuberous Sclerosis (Bourneville's Disease) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Bacterial Infections (Bacterial Infection) 12/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2019
1	Autoimmune Diseases (Autoimmune Disease) 10/2017
1	Hematologic Neoplasms (Hematological Malignancy) 10/2017
1	Legionnaires' Disease (Legionnaire's Disease) 06/2017
1	Chromosome Breakage 01/2016
1	Multiple Myeloma 07/2008

6	Adenosine Triphosphate (ATP)IBA 11/2023 - 01/2021
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2017
4	Adenosine Triphosphatases (ATPase)IBA 12/2022 - 06/2014
4	AntibodiesIBA 11/2022 - 11/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 01/2021
2	bedaquiline (R207910)IBA 01/2023 - 01/2021
1	Alkenes (Olefins)IBA 05/2023
1	Antineoplastic Agents (Antineoplastics)IBA 05/2023
1	DiarylquinolinesIBA 01/2023
1	Cytotoxins (Cytolysins)IBA 12/2022
1	ammocidinIBA 01/2022
1	Proton-Translocating ATPases (ATPase, H+)IBA 01/2022
1	apoptolidinIBA 01/2022
1	toosendaninIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	telacebecIBA 01/2021
1	EnzymesIBA 12/2020
1	Malaria VaccinesIBA 11/2020
1	Azacitidine (5 Azacytidine)FDA Link 10/2019
1	venetoclaxIBA 10/2019
1	Sialic Acid Binding Ig-like Lectin 2IBA 10/2017
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2016
1	ChromatinIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2010
1	Bortezomib (Velcade)FDA Link 07/2008

3	Therapeutics 05/2023 - 10/2017
1	Drug Therapy (Chemotherapy) 01/2022